Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Whitfield Roy A
Relationship:   Director
City:   San Carlos
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   885,185    

Indirect Shares

  71,500      
Direct Value   $39,065,027    

Indirect Value

  $90,805      
Total Shares   956,685      
Total Value   $39,155,832      


Incyte Corp
 $38,492,879 Illumina Inc
 $297,511 Nektar Therapeutics
 $274,638 Incyte Corp
 $38,492,879 Illumina Inc
 $297,511 Nektar Therapeutics
 $274,638
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director 2013-12-17 666,082 2006-12-21 0    Premium*  
            Illumina Inc ILMN Director 2016-08-12 2,853 2008-05-16 0    Premium*  
            Nektar Therapeutics NKTR Director 2023-06-14 216,250 2023-06-14 71,500    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
INCY Incyte Corp Director   –       •      –    2013-11-18 4 AS $47.37 $2,368,500 D/D (50,000) 621,082 0 -
INCY Incyte Corp Director   –       •      –    2013-08-19 4 AS $26.70 $1,335,000 D/D (50,000) 671,082 0 -
ILMN Illumina Inc Director   •       •      –    2015-07-06 4 AS $217.86 $981,478 D/D (4,500) 13,648 0 -
ILMN Illumina Inc Director   •       •      –    2015-08-05 4 AS $215.22 $968,490 D/D (4,500) 13,648 0 -
ILMN Illumina Inc Director   •       •      –    2015-06-05 4 AS $207.49 $933,705 D/D (4,500) 13,648 0 -
INCY Incyte Corp Director   –       •      –    2013-05-17 4 AS $23.08 $923,200 D/D (40,000) 721,082 0 -
ILMN Illumina Inc Director   –       •      –    2015-03-05 4 AS $191.80 $895,508 D/D (4,600) 11,738 0 -
ILMN Illumina Inc Director   •       •      –    2015-09-04 4 AS $192.63 $866,835 D/D (4,500) 13,648 0 -
ILMN Illumina Inc Director   –       •      –    2015-05-05 4 AS $188.42 $847,890 D/D (4,500) 11,738 0 -
ILMN Illumina Inc Director   •       •      –    2015-04-06 4 AS $181.32 $834,072 D/D (4,600) 11,738 0 -
ILMN Illumina Inc Director   –       •      –    2014-11-17 4 AS $178.26 $713,040 D/D (4,000) 11,738 0 -
ILMN Illumina Inc Director   •       •      –    2016-04-12 4 AS $170.00 $680,000 D/D (4,000) 1,800 0 -
ILMN Illumina Inc Director   –       •      –    2014-08-15 4 AS $169.28 $677,120 D/D (4,000) 11,738 0 -
ILMN Illumina Inc Director   •       •      –    2016-08-12 4 AS $167.22 $668,880 D/D (4,000) 2,853 0 -
ILMN Illumina Inc Director   •       •      –    2015-12-14 4 AS $175.07 $656,513 D/D (3,750) 13,648 0 -
INCY Incyte Corp Director   –       •      –    2013-02-19 4 AS $21.82 $654,600 D/D (30,000) 781,082 0 -
NKTR Nektar Therapeutics Director   –       •      –    2017-08-10 4 B $17.95 $628,250 D/D 35,000 133,000 2.39 -
ILMN Illumina Inc Director   –       •      –    2014-05-15 4 AS $143.71 $574,840 D/D (4,000) 9,196 0 -
NKTR Nektar Therapeutics Director   –       •      –    2021-09-16 4 OE $13.80 $552,000 D/D 40,000 225,850 0 -
ILMN Illumina Inc Director   •       •      –    2016-06-13 4 AS $140.44 $533,672 D/D (3,800) 2,853 0 -
ILMN Illumina Inc Director   •       •      –    2016-02-12 4 AS $140.30 $526,125 D/D (3,750) 1,800 0 -
ILMN Illumina Inc Director   –       •      –    2009-05-28 4 AS $35.33 $511,111 D/D (14,456) 3,200 0 -
INCY Incyte Corp Director   –       •      –    2010-10-25 4 S $16.93 $501,077 D/D (29,523) 927,082 0 -
INCY Incyte Corp Director   –       •      –    2012-05-24 4 S $22.27 $445,400 D/D (20,000) 821,082 0 -
NKTR Nektar Therapeutics Director   –       •      –    2018-04-17 4 OE $14.26 $427,800 D/D 30,000 172,000 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed